These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8361039)

  • 1. [Newly developed method by the use of factor Y assay for the detection of the lupus anticoagulant].
    Amagai H; Shizuka R; Hayakawa M; Kojima J; Fukumura Y; Kobayashi N; Kobayashi I
    Rinsho Byori; 1993 Jun; 41(6):713-8. PubMed ID: 8361039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of factor V activities in PT and APTT assays as a new diagnostic marker of lupus anticoagulant.
    Amagai H; Kanda T; Shizuka R; Fukumura Y; Kobayashi I
    Clin Lab Haematol; 1999 Feb; 21(1):45-9. PubMed ID: 10197263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
    Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
    Robert A
    Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance and lupus anticoagulant in pregnancy.
    Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
    J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting APC-resistant factor V: a functional method without plasma dilution.
    Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
    Clyne LP; Honig CL; Dainiak N
    Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acquired hemophilia A after an early abortion].
    Wullen B; Mühlhöfer A; Luz H; Zoller WG
    Dtsch Med Wochenschr; 2002 May; 127(20):1075-8. PubMed ID: 12016555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.